Browse Studies — Arctuva

Phase 1

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

This phase Ib trial tests the safety, side effects, and best dose of tumor treating fields therapy in combination with either cabozantinib or nab-paclitaxel an…

Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT05092373

Observational

Implementation of the American College of Surgeons Geriatric Surgery Verification Program at the James Cancer Hospital

This study examines how the American College of Surgeons Geriatric Surgery Verification Program, also called the ACS GSV Program, is implemented at the James C…

Breast CarcinomaMalignant Digestive System NeoplasmMalignant Female Reproductive System Neoplasm+9 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer Center

Phase 3

Pafolacianine for Localization of Pediatric Extracranial Solid Tumors

This phase III trial studies how well pafolacianine works for identifying cancerous lesions in children and adolescent patients with primary solid tumors or so…

Childhood Malignant Solid NeoplasmChildhood Malignant Thoracic NeoplasmMalignant Abdominal Neoplasm+3 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Mayo ClinicNCT06915727